| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xoma Royalty Corp (XOMA) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 25 sells. XOMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.32M | $54.62M | - | |
| CEO | 102.0K | $4.21M | - | |
| CFO | 30.1K | $1.24M | - | |
| CFO | 30.0K | $1.24M | - | |
| Dir | 23.8K | $984.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2017 | Neal James R76 | CEO | Sale+OE | 46,296 | $28.24 | $1,307,187.08 | -24.8% | |
| Nov 15, 2017 | Burns Thomas M.76 | SVP, Finance &CFO | Sale+OE | 22,222 | $28.69 | $637,450.42 | -27.6% | |
| May 16, 2017 | Varian John | Director | Sell | 39,540 | $6.24 | $246,919.39 | -94.4% | |
| Mar 21, 2017 | Neal James R76 | VP Business Development | Sell | 5,105 | $5.40 | $27,569.04 | -24.9% | |
| Mar 21, 2017 | Burns Thomas M.76 | VP, Finance &Chief Financial | Sell | 2,598 | $5.40 | $14,029.98 | -28.4% | |
| Feb 1, 2017 | Neal James R76 | VP Business Development | Sell | 195 | $4.52 | $880.50 | -0.5% | |
| Jan 9, 2017 | Neal James R76 | VP Business Development | Sell | 125 | $5.15 | $643.75 | -0.6% | |
| Dec 21, 2016 | Varian John | Director | Sell | 13,549 | $5.75 | $77,906.75 | -24.4% | |
| Dec 21, 2016 | Scannon Patrick J Md Phd | Exec. VP &CSO | Sell | 3,230 | $5.75 | $18,572.50 | -28.2% | |
| Nov 1, 2016 | Neal James R76 | VP Business Development | Sell | 150 | $5.25 | $787.50 | -0.7% |